Across TCGA pan-cancer cohorts, MIR619 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR619’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR619 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR619 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

KIRC, THCA, and THCA are the cancer types where MIR619 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR619 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	III,IV	+0.196	.031	3	view →
THCA	Male	II,III,IV	+0.381	.025	2	view →
THCA	Female	All	−0.140	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR619 RNA expression & survival · all MIR619 data types